Depressive symptoms, possible sarcopenia, and functional disability among Chinese adults aged 50 years or more: A five-wave longitudinal study.
Key claim: Co-occurring depressive symptoms and possible sarcopenia increase longitudinal functional disability risk in older adults beyond either exposure alone, though without synergistic interaction.
Abstract
OBJECTIVES: To examine separate and joint associations of baseline depressive symptoms and possible sarcopenia with repeatedly assessed functional disability among Chinese adults aged 50 years or more. STUDY DESIGN: Five-wave longitudinal cohort analysis, 2011-2020. MAIN OUTCOME MEASURES: The presence of depressive symptoms was defined as a score ≥ 10 on the 10-item Center for Epidemiologic Studies Depression Scale. Possible sarcopenia was defined as low handgrip strength determined using the 2025 Asian Working Group for Sarcopenia age- and sex-specific thresholds because directly measured muscle mass was unavailable. We assessed disability in terms of basic and instrumental activities of daily living, separately and jointly. Modified Poisson generalized estimating equations estimated risk ratios; logistic models provided standardized risks and risk differences with cluster-bootstrap confidence intervals. RESULTS: Of 9346 eligible participants, 8790 contributed 30,366 complete-case person-wave observations. Compared with neither exposure, adjusted risk ratios were 1.38 (95% confidence interval 1.32-1.44) for depressive symptoms only, 1.27 (1.18-1.37) for possible sarcopenia only, and 1.46 (1.38-1.56) for both. Standardized risks were 30.7%, 41.3%, 38.0%, and 46.0%, respectively. The risk difference for both versus neither was 15.3 percentage points (12.6-18.1). Additive interaction was -2.6 percentage points (-6.2 to 1.2), and the multiplicative interaction ratio was 0.84 (0.77-0.91). After multiple imputation, the contrast between the two single-exposure groups attenuated (risk ratio 1.06, 0.99-1.13). CONCLUSIONS: Participants with both exposures had the highest standardized risk, but there was no evidence of positive additive interaction and the joint association was less than multiplicative. The clinical usefulness of joint assessment requires prospective evaluation.
Why this matters
Co-occurring depressive symptoms and possible sarcopenia increase longitudinal functional disability risk in older adults beyond either exposure alone, though without synergistic interaction.